Induction of endoreduplication by a JNK inhibitor SP600125 in human lung carcinoma A 549 cells

Cell Biology International

Volumn 31, Issue 12, 2007, Pages 1501-1506

  Miyamoto Yamasaki, Yumi ^a   Yamasaki, Masao ^a,b   Tachibana, Hirofumi ^a   Yamada, Koji ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

Cell cycle; Endoreduplication; Mdm2; p53; SP600125

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; PROTEIN BAX; PROTEIN MDM2; PROTEIN P21; PROTEIN P53; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ARTICLE; CANCER INHIBITION; CARCINOMA CELL; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA CONTENT; DRUG EFFECT; ENDOREDUPLICATION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOPRECIPITATION; PROTEIN EXPRESSION;

ANTHRACENES; CARCINOMA; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DNA; DNA REPLICATION; G2 PHASE; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG NEOPLASMS; POLYPLOIDY; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-BCL-2; PROTO-ONCOGENE PROTEINS C-MDM2; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 35348938289     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2007.07.002     Document Type: Article

References (27)

1. Agapova L.S., Ivanov A.V., Sablina A.A., Kopnin P.B., Sokova O.I., Chumakov P.M., et al. p53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints. Oncogene 20 (1999) 3135-3142
2. Angel P., and Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072 (1991) 129-157
3. Barak Y., Juven T., Haffner R., and Oren M. The MDM2 expression is induced by wild type p53 activity. EMBO J 12 (1993) 461-468
4. Barboule N., Lafon C., Chadebech P., Vidal S., and Valette A. Involvement of p21 in the PKC-induced regulation of the G2/M cell cycle transition. FEBS Lett 444 (1999) 32-37
5. Bates S., Ryan K.M., Phillips A.C., and Vousden K.H. Cell cycle arrest and DNA endoreduplication following p21Waf1/Cip1 expression. Oncogene 17 (1998) 1691-1703
6. Chang K.-L., Kung M.-L., Chow N.-H., and Su S.-J. Genistein arrests hepatoma cells at G2/M phase: involvement of ATM activation and upregulation of p21waf1/cip1 and Wee1. Biochem Pharmacol 67 (2004) 717-726
7. Fuchs S.Y., Adler V., Buschmann T., Yin Z., Wu X., Jones S.N., et al. JNK targets p53 ubiquitination and degradation in nonstressed cells. Genes Dev 12 (1998) 2658-2663
8. Fuchs S.Y., Fried V.A., and Ronai Z. Stress-activated kinases regulate protein stability. Oncogene 17 (1998) 1483-1490
9. Grossman S.R., Deato M.E., Brignone C., Chan H.M., Kung A.L., Tagami H., et al. Polyubiquitination of p53 by a ubiquitin ligase activity of p300. Science 300 (2003) 342-344
10. Grossman S.R., Perez M., Kung A.L., Joseph M., Mansur C., Xiao Z.X., et al. p300/MDM2 complexes participate in MDM2-mediated p53 degradation. Mol Cell 2 (1998) 405-415
11. Gizatullin F., Yao Y., Kung V., Harding M.W., Loda M., and Shapiro G.I. The aurora kinase inhibitor VX-680 induces endoreduplication and apoptosis preferentially in cells with compromised p53-dependent postmitotic checkpoint function. Cancer Res 66 (2006) 7668-7677
12. Hagemann C., and Blank J.L. The ups and downs of MEK kinase interactions. Cell Signal 13 (2001) 863-875
13. Jochum W., Passegué E., and Wagner E.F. AP-1 in mouse development and tumorigenesis. Oncogene 20 (2001) 2401-2412
14. Karin M. Mitogen-activated protein kinase cascades as regulators of stress responses. Ann N Y Acad Sci 30 (1998) 139-146
15. Kussie P.H., Gorina S., Marechal V., Elenbaas B., Moreau J., Levine A.J., et al. Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain. Science 274 (1996) 948-953
16. Lai Z., Ferry K.V., Diamond M.A., Wee K.E., Kim Y.B., Ma J., et al. Human MDM2 mediates multiple mono-ubiquitination of p53 by a mechanism requiring enzyme isomerizaton. J Biol Chem 276 (2001) 31357-31367
17. Lei K., Nimnual A., Zong W.-X., Kennedy N.J., Flavell R.A., Thompson C.B., et al. The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH2-terminal kinase. Mol Cell Biol 22 (2002) 4929-4942
18. Li M., Brooks C.L., Wu-Bear F., Chen D., Bear R., and Gu W. Mono- versus polyubiquitination: differential control of p53 fate by Mdm2. Science 302 (2003) 1972-1975
19. Ling Y.-H., Liebes L., Jiang J.-D., Holland J.F., Elliott P.J., Adams J., et al. Mechanisms of proteasome inhibitor PS-341-induced G2-M-phase arrest and apoptosis in human non-small cell lung cancer cell lines. Clin Cancer Res 9 (2003) 1145-1154
20. Salvati F., Teodori L., Gagliardi L., Signora M., Aquilini M., and Storniello G. DNA flow cytometric studies of 66 human lung tumors analyzed before treatment. Prognostic implications. Chest 96 (1989) 1092-1098
21. Shaulian E., and Karin M. AP-1 in cell proliferation and survival. Oncogene 20 (2001) 2390-2400
22. Sinkins W.G., Vaca L., Hu Y., Kunze D.L., and Schilling W.P. The COOH-terminal domain of Drosophila TRP channels confers thapsigargin sensitivity. J Biol Chem 271 (1996) 2955-2960
23. Tafolla E., Wang S., Wong B., Leong J., and Kapila Y.L. JNK1 and JNK2 oppositely regulate p53 in signaling linked to apoptosis triggered by an altered fibronectin matrix: JNK links FAK and p53. J Biol Chem 20 (2005) 19992-19999
24. Tournier C., Hess P., Yang D.D., Xu J., Turner T.K., Nimnual A., et al. Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288 (2000) 870-874
25. Woo R.A., and Poon R.Y. Gene mutations and aneuploidy: the instability that causes cancer. Cell Cycle 3 (2004) 1101-1103
26. Yamada K., and Kimura G. Induction of endoreduplication in temperature-sensitive mutants of rat 3Y1 fibroblasts. J Cell Physiol 122 (1985) 210-214
27. Xu Y. Regulation of p53 responses by post-translational modifications. Cell Death Differ 10 (2003) 400-403